The second one was that the compounds could be cross-referenced with a PubChem ID. And the last one was the existing structural information (*.sdf files) of the compounds identified. The final selected compounds were approved before June 2024. We want to emphasize that this is the first version of MetAP DB; future versions will have metal-based approved drugs from recent years and will link with other research repositories.